Government Royalties On Sales Of Pharmaceutical And Other Biomedical Products Developed With Substantial Public Funding

Offers a detailed description of the successful technology transfer of an invention originating in intramural research within the US National Institutes of Health. The history of the commercialization of the invention is used to illustrate a new policy for the payment of royalties on the sales of biomedical products developed with public funding.